Video

Standard keratometry values perform better compared to total keratometry values in eyes undergoing concurrent cataract surgery and DMEK

Author(s):

Results concluded that K did better than TK in a variety of situations.

The study, “Accuracy of Multivariable IOL Formulas Using K and TK in Eyes. Undergoing Combined Cataract Surgery and DMEK," was presented by Asher Khan, BS, a research fellow at Dean McGee Eye Institute.

This retrospective review assessed and compared the accuracy of IOL formulas using K and TK values in eyes undergoing concurrent cataract surgery and DMEK.

Result takeaways:

  • K did better than TK
  • “Adjusted” K-6 performed the best
  • Multivariable formulas (Kane, K-6, EVO, and DGS) performed strongly
  • SRK/T also had a relatively strong performance
  • Haigis and Barrett did poorly with TK values

Conclusions:

  • IOL calculations remain challenging in combined phaco/DMEK eyes
  • Every formula performed better with K than with TK
  • Multivariable formulas (Kane, K-6, EVO, and DGS) with K values performed the best
  • While TK values can be helpful in other eyes (such as KCN or post-refractive), we advise that surgeons utilize K values when performing combined Phaco/DMEK surgery
"Use K when doing phaco/DMEK, K?" - Asher Khan, BS

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.